2-carboxyarabinitol 1-phosphate has been researched along with Leishmaniasis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dalzoto, LAM; Di Iorio, JF; Ferraz, LS; Judice, WAS; Lopes, RM; Machado, MFM; Rodrigues, T; Santos, TDR; Siqueira, FDS; Trujilho, MNR; Vianna, LDS | 1 |
1 review(s) available for 2-carboxyarabinitol 1-phosphate and Leishmaniasis
| Article | Year |
|---|---|
Cysteine proteases as potential targets for anti-trypanosomatid drug discovery.
Topics: Cysteine Proteases; Cysteine Proteinase Inhibitors; Drug Discovery; Humans; Leishmania; Leishmaniasis; Molecular Structure; Parasitic Sensitivity Tests; Trypanocidal Agents; Trypanosoma; Trypanosomiasis | 2021 |